Implantable cardiac monitors (ICMs) continuously monitor the patient's electrocardiogram and perform real-time analysis of the heart rhythm, for up to 36 months. The current clinical use of ICMs ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new ...
An autonomous platform uses machine learning and patterned light to detect and terminate cardiac arrhythmias in real time without electrical shocks.
Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed ...
Please provide your email address to receive an email when new articles are posted on . The FDA cleared a next-generation AI-powered remote ECG monitoring device. The ...
New study presented at HRX Live 2025 demonstrates continued advancement of company’s AI program HeartBeam's AI algorithm performed equally well on HeartBeam 3D ECG system and standard 12L ECGs in ...
Dr. Nassir Marrouche is director of the Heart and Vascular Institute at Tulane University with a subspecialty in electrophysiology. He treats atrial fibrillation, heart arrhythmia, irregular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results